Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
TCT 24: Sirolimus- vs. Paclitaxel-Coated Balloon Angioplasty
Author(s): Ulf Teichgräber Added: 1 year ago
TCT Conference 2024 - Safety and efficacy outcomes of the trial shows that percutaneous transluminal angioplasty (PTA) with the sirolimus drug coated balloon (DCB) in patients with femoropopliteal artery disease was/was not noninferior to PTA with the paclitaxel DCB.Prof Ulf Teichgräber joins us onsite at TCT Conference to discuss the findings from the sirolimus- vs. paclitaxel-coated balloon… View more

Intervention

Vascular Disease and Surgery
TCT 23: AGENT IDE
Author(s): Robert Yeh Added: 2 years ago
TCT 23 - In this short online interview, we are joined by Dr Robert Yeh (Beth Israel Deaconess Medical Center, US) to discuss the findings of the AGENT IDE trial (NCT04647253), sponsored by Boston Scientific. AGENT IDE is a prospective, 2:1 randomized multicenter trial that aimed to compare the AGENT paclitaxel-coated balloon to plain-old balloon angioplasty (POBA) with a commercially available… View more

Intervention
ESC 25: SWEDEPAD 1 and 2
Author(s): Marten Falkenberg , Joakim Nordanstig Added: 6 months ago
ESC Congress 2025 - Paclitaxel-coated devices in critical limb threatening ischemia were not effective in preventing amputation, nor improving quality-of-life in intermittent claudication.Dr Mårten Falkenberg (Sahlgrenska University Hospital, Gothenburg, SE) and Prof Joakim Nordanstig (Sahlgrenska University Hospital, Gothenburg, SE) join us to discuss findings from the SWEDEPAD 1 and 2 parallel… View more

Intervention

Vascular Disease and Surgery
TCT 2024 Late-Breaking Science Collection
Author(s): Dr Wissam A Jaber Added: 1 year ago
Keep informed with our video collection unveiling data from the Transcatheter Cardiovascular Therapeutics Conference in Washington. With expert insights on late-breaking trials and critical findings, you won't want to miss our #TCT24 coverage.For practice-focused reviews of the most anticipated trials, watch our recurring View From the Thoraxcenter series, hosted byProf Nicolas Van Mieghem and Dr… View more

Intervention
CRT 24: SYNTAX: PCI With TAXUS and CABG in Complex Coronary Disease
Author(s): Patrick W Serruys Added: 1 year ago
CRT 2024 — Prof Patrick W Serruys (National University of Ireland, Galway, US) joins us to discuss learning from the SYNTAX trial.The SYNTAX trial is a randomized controlled trial designed to evaluate the efficacy and safety of percutaneous coronary intervention (PCI) with polymer-based paclitaxel-eluting TAXUS stents versus coronary artery bypass grafting (CABG) in patients with complex coronary… View more

Intervention

Vascular Disease and Surgery
IN.PACT AV Access: Demographic Data from Post Approval Study
Author(s): Sanjay Misra Added: 10 months ago
Demographic data from the post-market IN.PACT AV Access Study suggests that the patient cohort had more complex lesions, allowing greater identification for subsets of groups that may need to be investigated.Dr Sanjay Misra (Mayo Clinic, Rochester, US) joins us to discuss the demographic data from the post-market IN.PACT AV Access approval study (NCT03041467; Medtronic Endovascular),… View more

Intervention

Vascular Disease and Surgery
Daniel JFM Thuijs
Research Area(s) / Expertise:
Dr Daniel Thuijs, MD, currently works as a PhD-fellow at the Department of Cardiothoracic Surgery, Erasmus MC. He will start his Residency in Cardiothoracic surgery in October '19. Daniel is involved in research regarding Cardiothoracic surgery and Cardiology. Currently, his main projects are, among others, (i) the "SYNTAX Extended Survival study" (10-year survival follow-up on patients (n=1800)… View more
TCT 23: Late-Breaking Clinical Trials Revealed
Added: 2 years ago Source:  Radcliffe Cardiology
Find out what's hot at TCT in this preview from Prof Nicolas Van Mieghem and Dr Joost Daemen The Cardiovascular Research Foundation (CRF) has unveiled the late-breaking clinical trials scheduled for presentation at the 2023 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting taking place from October 23 to 26 in San Francisco. TCT is renowned for showcasing groundbreaking research in… View more

Intervention